NCT00831064

Brief Summary

To compare 4 commonly used bowel preparations in terms of efficacy, patient tolerability and safety. All these 4 bowel preparations are likely to be efficacious and safe. However, those with lower volume are likely to be better tolerated and completed by patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2007

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2007

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

January 27, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 28, 2009

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2009

Completed
Last Updated

June 13, 2016

Status Verified

June 1, 2016

Enrollment Period

1.8 years

First QC Date

January 27, 2009

Last Update Submit

June 9, 2016

Conditions

Keywords

bowel preparation qualitycolonoscopy

Outcome Measures

Primary Outcomes (1)

  • bowel preparation quality as measured by the Ottawa scale

    at the time of endoscopy

Secondary Outcomes (2)

  • electrolyte and renal function abnormalities

    2 sets of measurements will be obtained: prior to the start of bowel preparation and at the time of colonoscopy

  • patient tolerability of bowel preparation

    at the time of colonoscopy

Study Arms (4)

1. 4L PEG only

ACTIVE COMPARATOR

4L PEG PO

Procedure: colonoscopy bowel prep

2. 2L PEG plus bisacodyl

ACTIVE COMPARATOR

2L PEG PO + 4 tablets bisacodyl PO

Procedure: colonoscopy bowel prep

3. NaP

ACTIVE COMPARATOR

90 cc NaP PO

Procedure: colonoscopy bowel prep

4. PSMC plus Mg-citrate

ACTIVE COMPARATOR

PSMC plus 300 cc Mg-citrate PO

Procedure: colonoscopy bowel prep

Interventions

PEG, bisacodyl, NaP, PSMC and Mg-citrate

1. 4L PEG only2. 2L PEG plus bisacodyl3. NaP4. PSMC plus Mg-citrate

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female between the ages of 18 and 75.
  • Planned elective outpatient colonoscopy.

You may not qualify if:

  • History of renal insufficiency or abnormal creatinine clearance with GFR \<59.
  • History of congestive heart failure.
  • History of acute coronary syndrome or unstable angina.
  • History of liver cirrhosis or ascites.
  • Chronic lasix therapy.
  • History of colorectal resection.
  • Known or suspected bowel obstruction, megacolon or ileus

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alberta Hospital

Edmonton, Alberta, Canada

Location

Related Publications (9)

  • Sharma VK, Chockalingham SK, Ugheoke EA, Kapur A, Ling PH, Vasudeva R, Howden CW. Prospective, randomized, controlled comparison of the use of polyethylene glycol electrolyte lavage solution in four-liter versus two-liter volumes and pretreatment with either magnesium citrate or bisacodyl for colonoscopy preparation. Gastrointest Endosc. 1998 Feb;47(2):167-71. doi: 10.1016/s0016-5107(98)70351-7.

    PMID: 9512283BACKGROUND
  • Rostom A, Jolicoeur E. Validation of a new scale for the assessment of bowel preparation quality. Gastrointest Endosc. 2004 Apr;59(4):482-6. doi: 10.1016/s0016-5107(03)02875-x.

    PMID: 15044882BACKGROUND
  • American Society of Colon and Rectal Surgeons (ASCRS); American Society for Gastrointestinal Endoscopy (ASGE); Society of American Gastrointestinal and Endoscopic Surgeons (SAGES); Wexner SD, Beck DE, Baron TH, Fanelli RD, Hyman N, Shen B, Wasco KE. A consensus document on bowel preparation before colonoscopy: prepared by a Task Force from the American Society of Colon and Rectal Surgeons (ASCRS), the American Society for Gastrointestinal Endoscopy (ASGE), and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Surg Endosc. 2006 Jul;20(7):1161. doi: 10.1007/s00464-006-3037-1. No abstract available.

    PMID: 16799744BACKGROUND
  • Rostom A, Jolicoeur E, Dube C, Gregoire S, Patel D, Saloojee N, Lowe C. A randomized prospective trial comparing different regimens of oral sodium phosphate and polyethylene glycol-based lavage solution in the preparation of patients for colonoscopy. Gastrointest Endosc. 2006 Oct;64(4):544-52. doi: 10.1016/j.gie.2005.09.030.

    PMID: 16996347BACKGROUND
  • Schmidt LM, Williams P, King D, Perera D. Picoprep-3 is a superior colonoscopy preparation to Fleet: a randomized, controlled trial comparing the two bowel preparations. Dis Colon Rectum. 2004 Feb;47(2):238-42. doi: 10.1007/s10350-003-0027-4.

    PMID: 15043296BACKGROUND
  • Barkun A, Chiba N, Enns R, Marcon M, Natsheh S, Pham C, Sadowski D, Vanner S. Commonly used preparations for colonoscopy: efficacy, tolerability, and safety--a Canadian Association of Gastroenterology position paper. Can J Gastroenterol. 2006 Nov;20(11):699-710. doi: 10.1155/2006/915368.

    PMID: 17111052BACKGROUND
  • Hookey LC, Vanner S. A review of current issues underlying colon cleansing before colonoscopy. Can J Gastroenterol. 2007 Feb;21(2):105-11. doi: 10.1155/2007/634125.

    PMID: 17299615BACKGROUND
  • Poon CM, Lee DW, Mak SK, Ko CW, Chan KC, Chan KW, Sin KS, Chan AC. Two liters of polyethylene glycol-electrolyte lavage solution versus sodium phosphate as bowel cleansing regimen for colonoscopy: a prospective randomized controlled trial. Endoscopy. 2002 Jul;34(7):560-3. doi: 10.1055/s-2002-33207.

    PMID: 12170410BACKGROUND
  • Frommer D. Cleansing ability and tolerance of three bowel preparations for colonoscopy. Dis Colon Rectum. 1997 Jan;40(1):100-4. doi: 10.1007/BF02055690.

    PMID: 9102248BACKGROUND

Study Officials

  • Sander van Zanten, MD

    University of Alberta

    STUDY DIRECTOR
  • Din a Kao, MD

    University of Alberta

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 27, 2009

First Posted

January 28, 2009

Study Start

September 1, 2007

Primary Completion

July 1, 2009

Study Completion

July 1, 2009

Last Updated

June 13, 2016

Record last verified: 2016-06

Locations